0 Commentarii
0 Distribuiri
129 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Exon-Skipping and Beyond: Tracking the Evolving Standard of Care and Pipeline Dynamics in the Multi-Billion Dollar Duchenne Muscular Dystrophy Market.The Duchenne Muscular Dystrophy (DMD) standard of care has been fundamentally altered by the introduction of exon-skipping oligonucleotide therapies. These drugs work by coaxing the cell's machinery to "skip" over a specific defective exon in the dystrophin gene, allowing the production of a truncated, but partially functional, dystrophin protein. While only applicable to specific genetic...0 Commentarii 0 Distribuiri 179 Views 0 previzualizare